Asian shares rise as US stimulus plans offset virus woes, delayed vaccines


By Swati Pandey SYDNEY (Reuters) - Asian shares rose on Monday as concerns over rising COVID-19 cases and delays in vaccine supplies were eclipsed by expectations of a $1.9 trillion fiscal stimulus plan to help revive the U.S. economy.

Global equity markets have scaled record highs in recent days on bets COVID vaccines will start to reduce the inflection rates worldwide and on a stronger U.S. economic recovery under President Joe Biden. Still, investors are also wary about towering valuations amid questions over the efficiency.

This article is no longer available in our repository.

There could be multiple reasons for this.